Modernizing – and Securing – Hospital Technology Infrastructure

The healthcare industry is experiencing a digital transformation driven by the need for improved patient outcomes, operational efficiency, and evolving technological trends. However, many hospitals face budget constraints that hinder their ability to modernize healthcare technology, leading to challenges with system integrations and security vulnerabilities. Prioritizing security, data governance, and embracing AI-based solutions are essential…

Read More

Fenofibrate reduces progression of diabetic eye disease

A study presented at the American Diabetes Association Scientific Sessions found that oral fenofibrate, a lipid-lowering drug, was associated with a 27% reduction in progression of diabetic eye disease over 4 years. This drug, repurposed for the LENS trial, showed significant benefits in reducing diabetic retinopathy and maculopathy. The study involved over 1,100 adults with…

Read More

Chiropractors have been banned again from manipulating babies’ spines. Here’s what the evidence actually says

Chiropractors in Australia are once again banned from performing spinal manipulation on children under the age of two due to health concerns. The controversy arose from a video showing a chiropractor manipulating a two-week-old baby’s spine. The evidence on the effectiveness and safety of spinal manipulation in babies is limited, with few studies showing a…

Read More

Sobi’s ALTUVOCT receives EU marketing authorization

Sobi® has received Marketing Authorization from the European Commission for ALTUVOCT™ (efanesoctocog alfa) for the treatment of hemophilia A. ALTUVOCT is a sustained factor VIII replacement therapy for all ages that can significantly reduce bleeds with once-weekly prophylaxis. The EMA also endorsed ALTUVOCT’s orphan drug designation, granting a 10-year market exclusivity period. Studies have shown…

Read More

Delaying Statin Therapy in Diabetes Increases CV Risk

Delaying treatment with recommended statin therapy for patients with type 1 and 2 diabetes leads to significantly higher rates of cardiovascular events over a 10-year follow-up period. Those who accepted the recommended statin therapy from the start had a 6.4% risk of adverse CV events, compared to 8.5% for those who delayed. The risk for…

Read More

Medicare Telehealth Flexibilities Will Expire In December. Congress Needs To Act Swiftly, Experts Say

Before Covid-19, only a small number of Medicare beneficiaries had access to virtual care, limited to those in rural areas. Covid-19 waivers expanded telehealth access, but these are set to expire on December 31 unless Congress acts. Advocates are calling for an extension to ensure continued access. CMS must establish Medicare payment policies by January…

Read More

A Tale of Two States: Arizona and Florida Diverge on How To Expand Kids’ Health Insurance

Arizona and Florida, states with high rates of uninsured children, set goals to expand health insurance for those 18 and younger. However, their plans highlight differences in charging low-income families for premiums and consequences for missed payments. Arizona aligned with the Biden administration, suspending monthly premiums for KidsCare. In contrast, Florida has yet to start…

Read More
error: Content is protected !!